TY - JOUR
T1 - Survey results for in vitro-in vivo correlations (IVIVC)
T2 - Critical variables for success
AU - Fotaki, Nikoletta
AU - Gray, V.
AU - Kesisoglou, F.
AU - Mayock, S.
AU - Mirza, T.
AU - Salt, A.
N1 - Conference abstract
PY - 2013/5
Y1 - 2013/5
N2 - This report summarizes the results of the "In Vitro-In Vivo Correlations (IVIVC): Critical Variables for Success" survey orga- nized by the In Vitro Release and Dissolution Testing (IVRDT) and the QbD and Product Performance AAPS Focus Groups. This was a web-based survey conducted over a 26-day period from Wednesday, June 29, 2011, to Sunday, July 24, 2011, and results were initially presented at the 2011 AAPS Annual Meeting and Exposition. The goal was to describe the current views from scientists across academia, industry, and regulatory agencies on the adoption, utility, and benefits of IVIVCs and to begin identifying potentially critical variables for their success. Questions in the survey cover their development, use, and success.
AB - This report summarizes the results of the "In Vitro-In Vivo Correlations (IVIVC): Critical Variables for Success" survey orga- nized by the In Vitro Release and Dissolution Testing (IVRDT) and the QbD and Product Performance AAPS Focus Groups. This was a web-based survey conducted over a 26-day period from Wednesday, June 29, 2011, to Sunday, July 24, 2011, and results were initially presented at the 2011 AAPS Annual Meeting and Exposition. The goal was to describe the current views from scientists across academia, industry, and regulatory agencies on the adoption, utility, and benefits of IVIVCs and to begin identifying potentially critical variables for their success. Questions in the survey cover their development, use, and success.
UR - http://www.scopus.com/inward/record.url?scp=84878906307&partnerID=8YFLogxK
UR - http://www.dissolutiontech.com/
UR - http://www.dissolutiontech.com/DTresour/201305Articles/DT201305_A07.pdf
M3 - Article
SN - 1521-298X
VL - 20
SP - 48
EP - 50
JO - Dissolution Technologies
JF - Dissolution Technologies
IS - 2
ER -